Quality of life scores predict outcome in metastatic but not in early breast cancer

Breast

Volumn 10, Issue , 2001, Pages 164-170

  Coates, A S ^a   Hurny C ^b   Peterson, H F ^c   Bernhard, J ^d   Castiglione Gertsch, M ^e   Gelber, R D ^c   Goldhirsch, A ^a,b,c,d,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Bürgerspital   (Switzerland)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d IBCSG Coordinating Center   (Switzerland)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

APPETITE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE COURSE; DISEASE SEVERITY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; LANGUAGE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MOOD; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL MODEL; WELLBEING;

EID: 0034921708     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(16)30027-3     Document Type: Article

References (33)

1. Evaluation of quality of life in patients receiving treatment for advanced breast cancer
2. Improving the quality of life in advanced breast cancer. A comparison of continuous and intermittent treatment strategies
3. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer
4. Quality of life assessment. An independent prognostic variable for survival in lung cancer
5. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic melanoma
6. Coping, distress, and survival among patients with lung cancer
7. Psychological response to breast cancer: Effect on outcome
8. Influence of psychological response on survival in breast cancer: A population-based cohort study
9. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
10. Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients
11. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients
12. Quality of life measures for patients receiving adjuvant therapy for breast cancer: An international trial
13. The Perceived Adjustment to Chronic Illness Scale (PACIS): A global indicator of coping for operable breast cancer patients in clinical trials
14. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach
15. Regression models and life tables
16. Factors affecting baseline quality of life in two international adjuvant breast cancer trials
17. On the receiving end. IV: Validation of quality of life indicators
18. Responsiveness of a single-item item indicator versus a multi-item scale: Assessment of emotional wellbeing in an international breast cancer trial
19. On the receiving end VI. Which dimensions of quality of life scores carry prognostic information?
20. Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy
21. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being
22. Prognostic value of quality of life scores in terminal cancer patients
23. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma
24. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer
25. The effect of psychosocial treatment on survival of patients with metastatic breast cancer
26. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: Survival results of a trial
27. Malignant melanoma. Effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later
28. Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways
29. Coping and survival in patients with primary breast cancer: A critical analysis of current research strategies and proposal of a new approach integrating biomedical, psychological and social variables
30. Do psychosocial factors influence the course of breast cancer? A review of recent literature, methodological problems and future directions
31. Coping and survival in early breast cancer: An update
32. Psychoneuroimmunology and the course of breast cancer: An overview. The impact of psychosocial factors on the progression of breast cancer through immune and endocrine mechanisms
33. Psychological symptoms and disease-free and overall survival in women with stage II breast cancer